Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density
暂无分享,去创建一个
Jack Cuzick | Diana S. M. Buist | Adam R. Brentnall | J. Cuzick | D. Buist | A. Brentnall | E. Bowles | Erin J. Aiello Bowles
[1] S. Duffy,et al. Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[2] Karla Kerlikowske,et al. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.
[3] Karla Kerlikowske,et al. One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[4] Emily White,et al. Evaluating Organized Breast Cancer Screening Implementation , 2004, Cancer Epidemiology Biomarkers & Prevention.
[5] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[6] Arika E. Wieneke,et al. Validation of natural language processing to extract breast cancer pathology procedures and results , 2015, Journal of pathology informatics.
[7] D G Altman,et al. The benefits and harms of breast cancer screening: an independent review , 2013, British Journal of Cancer.
[8] K. Kerlikowske,et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. , 1997, AJR. American journal of roentgenology.
[9] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.
[10] S. Fedewa,et al. Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening , 2015, CA: a cancer journal for clinicians.
[11] L. Liberman,et al. Breast imaging reporting and data system (BI-RADS). , 2002, Radiologic clinics of North America.
[12] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[13] C. Vachon,et al. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Stephen W Duffy,et al. A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.
[15] Konstantin Strauch,et al. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance , 2012, Breast Cancer Research.
[16] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .
[17] C. Lehman,et al. Identifying women with dense breasts at high risk for interval cancer: a cohort study. , 2015, Annals of internal medicine.
[18] S. Cummings,et al. Risk Factors That Increase Risk of Estrogen Receptor–Positive and –Negative Breast Cancer , 2017, Journal of the National Cancer Institute.
[19] Karla Kerlikowske,et al. Screening Mammography Use among Current, Former, and Never Hormone Therapy Users May Not Explain Recent Declines in Breast Cancer Incidence , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[20] Karla Kerlikowske,et al. The contributions of breast density and common genetic variation to breast cancer risk. , 2015, Journal of the National Cancer Institute.
[21] D. Saslow,et al. Cancer screening in the United States, 2011 , 2011, CA: a cancer journal for clinicians.
[22] Susan M. Astley,et al. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort , 2015, Breast Cancer Research.
[23] S. Wood. Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models , 2011 .
[24] Mitchell H Gail,et al. Comparing breast cancer risk assessment models. , 2010, Journal of the National Cancer Institute.
[25] J. Cuzick,et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] A Howell,et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme , 2003, Journal of medical genetics.
[27] Identifying Women With Dense Breasts at High Risk for Interval Cancer , 2015, Annals of Internal Medicine.
[28] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[29] Stephen W Duffy,et al. Risk determination and prevention of breast cancer , 2014, Breast Cancer Research.
[30] A. LaCroix,et al. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data , 2013, The Lancet.
[31] Stephen W Duffy,et al. Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I , 2014, Breast Cancer Research.
[32] P. Grambsch,et al. A Package for Survival Analysis in S , 1994 .